EC5026

Asset

Soluble epoxide hydrolase (sEH) inhibitor

Stage
Phase 1
Modality
Small molecule
Target
Not known
7
Indications
6
Trials
1
Developer

3 trials are still running. Trial NCT07694544 updated in its registry on Jul 10, 2026. clinicaltrials.gov

Indications

7

4 more

In the full profile

  • Owner and partners1
  • Trials6
  • Competitors12
  • Aging relevance1
  • Signals1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets